GlassScriptPhysician profile
Chasity L Epperson
NPI 1053654970
$749.90
in general payments reported to CMS, 2019-2025
11 companies · $92.08 in 2025
The $92.08 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $158 · 2022: $104 · 2023: $294 · 2024: $101 · 2025: $92.08.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $487.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $487.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tandem Diabetes Care, INC. | $166.74 | 2022-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Insulet Corporation | $163.51 | 2023-2024 | Omnipod |
| Dexcom, INC. | $83.72 | 2022-2024 | Dexcom G6 Transmitter |
| Medtronic, INC. | $81.55 | 2021-2025 | Minimed 780g |
| Mannkind Corporation | $78.02 | 2021 | |
| Beta Bionics, INC. | $41.88 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Abbott Laboratories | $39.95 | 2023-2024 | Freestyle Libre 3 |
| Radius Health, INC. | $33.45 | 2021-2022 | |
| Ascendis Pharma Endocrinology INC | $24.76 | 2023 | |
| Xeris Pharmaceuticals, INC. | $18.58 | 2021 | |
| Sequel Med Tech, LLC | $17.74 | 2025 | Twiist |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chasity Epperson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.